Belgija – Farmacijos produktai – framework contract for the supply of the latest approved protein based COVID-19 vaccines
Belgija – Farmacijos produktai – framework contract for the supply of the latest approved protein based COVID-19 vaccines
I dalis: Perkančioji organizacija
I.1) Pavadinimas ir adresai:
Oficialus
pavadinimas: European Commission, DG HERA - European Health Emergency Preparedness and Response Authority
Adresas: L-15 2/P097
Miestas: Brussels
Pašto
kodas: B-1049
Šalis: Belgija
Asmuo
ryšiams:
El-paštas: HERA-JOINT-PROCUREMENT-secretariat@ec.europa.eu
Interneto adresas (-ai):
II dalis: Objektas
II.1.1) Pavadinimas:
framework contract for the supply of the latest approved protein based COVID-19 vaccines
Nuorodos numeris: EC-HERA/2024/CPN/0006
II.1.2) Pagrindinis BVPŽ kodas:
33600000
Farmacijos produktai
II.1.3) Sutarties tipas:
Kita
II.1.4) Trumpas aprašymas:
The subject of this contract is the supply of the latest approved protein based COVID-19 vaccines up to 4,000,000 doses. Throughout the delivery schedule and/or duration of the contract (whichever lasts longer), the contractor shall ensure that the vaccine is adapted to the relevant variants for the European Union population and ensure availability of adapted vaccines in accordance with the most recent Experts recommendations on the need for updating the strain composition of C19 vaccines. The necessity of adapting the vaccine shall be assessed at least yearly, on time, to start timely distribution of updated vaccines for vaccination during second half of the year, unless other timing of updates is considered necessary. The contractor shall also ensure any other relevant changes to the vaccine, as necessary, to address efficacy and safety needs of the product and to enable adequate immunization activities by the participating countries.
II.2) Aprašymas:
II.2.1) Kitas (-i) šio pirkimo BVPŽ kodas (-ai):
33600000 Farmacijos produktai